Lung Cancer Therapeutics Sales are slated to surge at a CAGR of 15.0% during the forecast period – Genentech (F. Hoffmann-La Roche Ltd), Eli Lilly and Company, Celgene Corporation, AstraZeneca
The global lung cancer therapeutics market was valued at USD 18.3 billion in 2021 and it is anticipated to grow further till USD 74.1 billion …